Status:
COMPLETED
Bypass Angioplasty Revascularization Investigation (BARI)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Angina Pectoris
Cardiovascular Diseases
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To assess the relative long-term safety and efficacy of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) surgery in patients with multivessel disease and s...
Detailed Description
BACKGROUND: The management of patients with symptomatic coronary heart disease has evolved considerably in the past twenty years with the application of invasive techniques in an ever increasing prop...
Eligibility Criteria
Multivessel coronary artery disease requiring revascularization and suitable for either PTCA or CABG.
Key Trial Info
Start Date :
April 1 1987
Trial Type :
INTERVENTIONAL
End Date :
November 1 2004
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000462
Start Date
April 1 1987
End Date
November 1 2004
Last Update
May 13 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.